Literature DB >> 10758960

Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: the Copenhagen City Heart Study.

R Frikke-Schmidt1, A Tybjaerg-Hansen, R Steffensen, G Jensen, B G Nordestgaard.   

Abstract

OBJECTIVES: We tested the hypothesis that risk of ischemic heart disease (IHD) differs as a function of apolipoprotein E (APOE) genotype in women and men.
BACKGROUND: Apolipoprotein E genotype influences lipids and lipoproteins and, therefore, possibly the risk of IHD.
METHODS: We genotyped 9,241 white women and men from the general population and 940 white women and men with IHD.
RESULTS: Test of interaction suggested that APOE genotype may influence risk of IHD differently in women and men (p = 0.07). After age adjustment, the odds ratio (OR) for IHD for epsilon32 versus epsilon33 women was 0.57 (95% confidence interval [CI]: 0.35 to 0.94) while epsilon43 and epsilon44 versus epsilon33 men had ORs of 1.16 (0.96 to 1.41) and 1.58 (1.01 to 2.45). After adjustment for age and other conventional cardiovascular risk factors, the equivalent ORs were for epsilon32 women 0.38 (0.18 to 0.79), for epsilon43 men 1.35 (1.02-1.78) and for epsilon44 men 1.58 (0.80 to 3.08). Equivalent ORs for epsilon43 and epsilon44 versus epsilon33 women and for epsilon32 versus epsilon33 men were all close to 1.0 and nonsignificant. Of the total risk of IHD relative to the epsilon33 genotype, the fraction attributed to epsilon32 in women was -9%, while the fractions attributed to epsilon43 and epsilon44 in men were +8% and +2%.
CONCLUSIONS: Relative to epsilon33 individuals, epsilon32 women are protected while epsilon43 and epsilon44 men are particularly susceptible to IHD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10758960     DOI: 10.1016/s0735-1097(00)00520-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  12 in total

1.  An application of the patient rule-induction method for evaluating the contribution of the Apolipoprotein E and Lipoprotein Lipase genes to predicting ischemic heart disease.

Authors:  Greg Dyson; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Charles F Sing
Journal:  Genet Epidemiol       Date:  2007-09       Impact factor: 2.135

2.  Trade-off in the effect of the APOE gene on the ages at onset of cardiocascular disease and cancer across ages, gender, and human generations.

Authors:  Alexander M Kulminski; Irina Culminskaya; Konstantin G Arbeev; Svetlana V Ukraintseva; Liubov Arbeeva; Anatoli I Yashin
Journal:  Rejuvenation Res       Date:  2013-02       Impact factor: 4.663

3.  Apolipoprotein E Genotype and Cardiovascular Diseases in the Elderly.

Authors:  Mary N Haan; Elizabeth R Mayeda
Journal:  Curr Cardiovasc Risk Rep       Date:  2010-07-16

4.  Health-protective and adverse effects of the apolipoprotein E epsilon2 allele in older men.

Authors:  Alexander M Kulminski; Svetlana V Ukraintseva; Konstantin G Arbeev; Kenneth G Manton; Junko Oshima; George M Martin; Dora Il'yasova; Anatoli I Yashin
Journal:  J Am Geriatr Soc       Date:  2008-01-04       Impact factor: 5.562

5.  Variation in 5' promoter region of the APOE gene contributes to predicting ischemic heart disease (IHD) in the population at large: the Copenhagen City Heart Study.

Authors:  J H Stengård; R Frikke-Schmidt; A Tybjaerg-Hansen; B G Nordestgaard; C F Sing
Journal:  Ann Hum Genet       Date:  2007-05-29       Impact factor: 1.670

6.  Apolipoprotein E genotype, lipid levels and coronary heart disease in a Polish population group.

Authors:  M Bednarska-Makaruk; G Broda; P Kurjata; M Rodo; M Roszczynko; S Rywik; H Wehr
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

7.  Gender- and age-specific contributions of additional DNA sequence variation in the 5' regulatory region of the APOE gene to prediction of measures of lipid metabolism.

Authors:  Ruth Frikke-Schmidt; Charles F Sing; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Journal:  Hum Genet       Date:  2004-09       Impact factor: 4.132

8.  Association between apolipoprotein E polymorphism and subclinic atherosclerosis in patients with type 1 diabetes mellitus.

Authors:  Mehmet Emre Atabek; Yusuf Özkul; Beray Selver Eklioğlu; Selim Kurtoğlu; Murat Baykara
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-03

9.  Associations between apolipoprotein E genotype, diet, body mass index, and serum lipids in Lithuanian adult population.

Authors:  Janina Petkeviciene; Alina Smalinskiene; Dalia Ieva Luksiene; Kristina Jureniene; Vitalija Ramazauskiene; Jurate Klumbiene; Vaiva Lesauskaite
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

10.  Association between APOE, SCARB1, PPARα polymorphisms and serum lipids in a population of Lithuanian adults.

Authors:  Alina Smalinskiene; Janina Petkeviciene; Dalia Luksiene; Kristina Jureniene; Jurate Klumbiene; Vaiva Lesauskaite
Journal:  Lipids Health Dis       Date:  2013-08-06       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.